UCLA Health
At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.
ASCO GI 2023 Phase 3 STELLAR-303 Study: XL092 in Combination With Atezolizumab vs. Regorafenib in Patients With Previously Treated mCRC
By
ASCO GI 2023 Conference Coverage
FEATURING
J. Randolph Hecht
By
ASCO GI 2023 Conference Coverage
FEATURING
J. Randolph Hecht
Login to view comments.
Click here to Login